Advancements in advanced prostate cancer

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/28

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

29 Terms

1
New cards
What is the leading cause of cancer-related deaths in the US among men?
Prostate cancer is the second leading cause of cancer-related deaths.
2
New cards
Which racial group has the highest incidence and mortality rates for prostate cancer?
Black men experience higher risk and mortality rates for prostate cancer compared to any other racial or ethnic group.
3
New cards
What does the 2023 AUA/SUO Guideline aim to address in prostate cancer management?
The guideline provides updated evidence-based recommendations for the management of advanced prostate cancer.
4
New cards
What is the significance of PSMA PET imaging in prostate cancer management?
PSMA PET imaging enhances the sensitivity and specificity in the detection of metastatic diseases.
5
New cards
What are some common types of advanced prostate cancer according to the latest guidelines?
Metastatic hormone-sensitive prostate cancer (mHSPC) and non-metastatic castration-resistant prostate cancer (nmCRPC) are common types.
6
New cards
What genetic mutations are associated with hereditary prostate cancer?
BRCA1 and BRCA2 mutations are associated with hereditary prostate cancer.
7
New cards
What is the purpose of using androgen deprivation therapy (ADT) in mHSPC?
ADT is used in combination with other therapies to improve treatment outcomes in metastatic hormone-sensitive prostate cancer.
8
New cards
What is the role of PSADT in prostate cancer assessment?
PSA doubling time (PSADT) is used to assess disease progression and identify high-risk patients.
9
New cards
What emerging therapeutic target is mentioned for prostate cancer treatment?
The androgen receptor (AR) is a therapeutic target in prostate cancer treatment.
10
New cards
What is one of the ongoing investigations regarding disparities in prostate cancer?
Research is ongoing into screening practices and access to care for Black men.
11
New cards
Which treatment combination is emphasized for mCRPC according to the guidelines?
ADT with abiraterone acetate plus prednisone, docetaxel, or enzalutamide is recommended.
12
New cards
What type of cancer is the most prevalent among men globally?
Prostate cancer is one of the most prevalent cancers affecting men globally.
13
New cards
Which gene fusion is commonly observed in prostate cancer?
TMPRSS2-ERG fusion is commonly observed and linked to the development of prostate tumors.
14
New cards
What is the significance of the updated guidelines for healthcare professionals?
The updated guidelines serve as a critical resource for healthcare professionals managing advanced prostate cancer.
15
New cards
What role does imaging play in the management of nmCRPC?
Imaging, particularly PSMA PET, enhances monitoring and treatment planning for nmCRPC patients.
16
New cards
What unmet need is highlighted in the management of prostate cancer?
There is a demand for personalized care and addressing disparities in patient outcomes.
17
New cards
What outcomes do biomarkers like MSI and tumor mutational burden predict?
They predict responses to therapies such as PARP inhibitors in prostate cancer treatment.
18
New cards
What is the purpose of metastasis-directed therapy (MDT) in advanced prostate cancer?
MDT aims to target metastatic lesions with techniques like radiation or surgery.
19
New cards
What new treatment option is introduced for progressive mCRPC based on PSMA PET imaging?
177Lu-PSMA-617 is a new treatment option for progressive metastatic castration-resistant prostate cancer.
20
New cards
What advantage does personalized care offer in prostate cancer treatment?
Personalized care can enable tailored treatment approaches to improve patient outcomes.
21
New cards
What is the goal of therapeutic decision-making in mHSPC and mCRPC?
The goal is to utilize evidence-based recommendations for effective treatments.
22
New cards
How does the AUA/SUO guideline address the issue of biochemical recurrence?
It provides updated recommendations for patients with rising PSA levels after local therapy.
23
New cards
What kind of research is being conducted to enhance treatment for Black men with prostate cancer?
There is ongoing investigation to enhance early detection and intervention strategies for Black men.
24
New cards
What does the term 'theranostics' refer to in prostate cancer treatment?
Theranostics integrates diagnostic and therapeutic strategies for precision-guided therapy.
25
New cards
What is one of the effects of chemotherapy in mHSPC patients according to guidelines?
Chemotherapy supports significant extensions in overall survival and progression-free survival.
26
New cards
What will regular imaging evaluations for nmCRPC potentially enhance?
Regular imaging can enhance the early detection of metastatic progression.
27
New cards
Why is understanding the sequence of therapies important in prostate cancer management?
The optimal sequencing of therapies can lead to improved treatment outcomes and reduced side effects.
28
New cards
What treatment technologies are part of the burgeoning interest in advanced prostate cancer management?
Technologies such as radiation, surgery, or ablative approaches are part of this interest.
29
New cards
What does the guideline suggest about immunotherapy in advanced prostate cancer?
Immunotherapy shows less efficacy in prostate cancer compared to other malignancies.